On 1/15/2020 ADiTxt filed the paperwork for their $25 Million IPO. The offering will consist of common stock and warrants. The Loma Linda, CA based company is focused on developing treatments that... read more
On 1/15/2020 ADiTxt filed the paperwork for their $25 Million IPO. The offering will consist of common stock and warrants. The Loma Linda, CA based company is focused on developing treatments that... read more
Team uses math – “the new microscope” – to demonstrate that men and women react differently to blood pressure medication
On 1/6/2020 Mirum Pharmaceuticals filed the paperwork for a $... read more
On 1/6/2020, Arcutis Biotherapeutics filed the paperwork for their $100 Million IPO. The Westlake Village, CA based company is focused on developing and commercializing treatments for... read more
On January 2, 2020 Avadim Health filed the paperwork for a $50 million IPO. The fast growing Asheville, NC based company provides non-prescription topical products to improve immune health,... read more
On 12/17/19 PDS Biotechnology filed the paperwork for a $13.8 million offering of its common stock. The New Brunswick, NJ based company is developing off-the-shelf cancer immunotherapies, based on... read more
On 12/13/19 Processa Pharmaceuticals filed for a $15 million offering of common stock. The Hanover, MD based company focuses on acquiring and developing drugs that already have some proof-of-... read more
Karuna Therapeutics filed the paperwork for a $52 Million offering on 11/18/19. The Boston, MA based company focuses on developing treatments for neurological disorders and currently has develop... read more
Biocept filed for a $27+ Million offering of stock and warrants on 11/1/19. Biocept provides molecular oncology diagnostics and is based in San Diego, CA. The company trades on NASDAQ under the... read more
The 14th Annual Cardiometabolic Health Congress was held in Chicago IL, October 10 – 13, 2019 and focused on both prevention and management of... read more
Chardan Healthcare Acquisition Corp. Shareholders Approve Definitive Merger Agreement with BiomX Ltd.
Chardan Healthcare Acquisition Corp. (NYSE: CHAC, “CHAC”), a special... read more
TELA Bio filed the paperwork for a $69 Million IPO on 10/15/2019. The Malvern, PA based company makes interwoven biologic tissue devices used in hernia repair and abdominal wall reconstruction.... read more
Frequency Therapeutics updated its $123 Million IPO on 9/23/19. The Woburn, Ma based company is focused on on harnessing the body’s innate biology to repair or reverse damage caused by a broad... read more
